When testosterone (T) or dihydrotestosterone (DHT) pellets (15 mg) were implanted into host male rats of different ages bearing ventral prostate transplants obtained from donors of varying ages, the in situ tissues generally contained more DNA than did the transplanted tissues. Hosts implanted with T, and in particular in the transplanted ventral prostate tissues, contained higher levels of DNA than in those hosts implanted with DHT. Neither the donor or host age (6–12 weeks) nor the duration of the transplant (6 or 12 weeks) seemed to have any demonstrable effect upon the levels of DNA in the transplant itself or in the in situ prostate. The in vitro incubations of slices of either the transplant or the host’s prostate with testosterone-3H revealed that both tissues could effectively synthesize dihydrotestosterone-3H and androstanediol-3H. However, the transplanted tissue was less capable of such steroid metabolism, and overall was 1/3–1/2 as effective as the host prostate tissues in vitro. The acinar epithelial cell heights and the cellular secretory activities in the transplants were often similar to those examined from the host’s in situ ventral prostate. Prolactin (50 IU/kg daily × 5) did not affect DNA levels in either the transplants or the in situ prostate, but this hormone did accelerate the formation of DHT-3H in the in situ prostate in vitro.

Keywords:
Testosterone, Dihydrotestosterone, Prostate transplant, Androgen metabolism, Prostate DNA, Prolactin
This content is only available via PDF.
© 1977 S. Karger AG, Basel
1977
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.